Yu Zhao
Zixian Zhao
Dandan Li
Hao Nie
Yufen Sun
Xiaobei Feng
Ting Zhang
Yu Ma
Jing Nie
Guangyan Cai
Xiangmei Chen
Wei Zuo
1 East Hospital, School of Medicine, Tongji University, Shanghai 200092, China;
2 Regend Therapeutics Co. Ltd., Zhangjiang Hi-tech Park, Shanghai 201203, China;
3 Ningxia Medical University, Yinchuan 750004, China;
4 The First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510120, China;
5 Ruijin Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200025, China;
6 State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Key Laboratory of Organ Failure Research, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China;
7 National Clinical Research Center for Kidney Diseases, State Key Laboratory of Kidney Diseases, Chinese PLA General Hospital, Beijing 100039, China
Funds: We thank Prof. Fanfan Hou for valuable suggestion for this project. This work was funded by the National Key Research and Development Program of China (2017YFA0104600 to W. Zuo, and 2018YFA0108800 to G. Cai), National Science Foundation of China (81770073 to W. Zuo), Shanghai Science and Technology Talents Program (19QB1403100 to W. Zuo), Youth 1000 Talent Plan of China to W. Zuo, Tongji University (Basic Scientific Research Interdisciplinary Fund and 985 Grant to W. Zuo) and Guangzhou Medical University annual grant to W. Zuo.
Abstract
PDF全文下载地址:
http://www.protein-cell.org/article/exportPdf?id=163318a3-6272-47d7-98ea-8d4aff2049d7&language=en
